Erratum for

• Design, synthesis, and biological evaluation of biotinylated colchicine derivatives as potential antitumor agents.

  Wang C, Zhang Y, Wang Z, Li Y, Guan Q, Xing D, Zhang W. Wang C, et al. J Enzyme Inhib Med Chem. 2022 Dec;37(1):411-420. doi: 10.1080/14756366.2021.2013832. J Enzyme Inhib Med Chem. 2022. PMID: 34915785 Free PMC article.
• 1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies.

  Hagras M, Saleh MA, Ezz Eldin RR, Abuelkhir AA, Khidr EG, El-Husseiny AA, El-Mahdy HA, Elkaeed EB, Eissa IH. Hagras M, et al. J Enzyme Inhib Med Chem. 2022 Dec;37(1):380-396. doi: 10.1080/14756366.2021.2015342. J Enzyme Inhib Med Chem. 2022. PMID: 34923885 Free PMC article.
• 2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights.

  Elbadawi MM, Eldehna WM, Abd El-Hafeez AA, Somaa WR, Albohy A, Al-Rashood ST, Agama KK, Elkaeed EB, Ghosh P, Pommier Y, Abe M. Elbadawi MM, et al. J Enzyme Inhib Med Chem. 2022 Dec;37(1):349-372. doi: 10.1080/14756366.2021.2015344. J Enzyme Inhib Med Chem. 2022. PMID: 34923887 Free PMC article.
• Flavonoids as tyrosinase inhibitors in in silico and in vitro models: basic framework of SAR using a statistical modelling approach.

  Jakimiuk K, Sari S, Milewski R, Supuran CT, Şöhretoğlu D, Tomczyk M. Jakimiuk K, et al. J Enzyme Inhib Med Chem. 2022 Dec;37(1):421-430. doi: 10.1080/14756366.2021.2014832. J Enzyme Inhib Med Chem. 2022. PMID: 34923888 Free PMC article.
• Design and synthesis of chromone-nitrogen mustard derivatives and evaluation of anti-breast cancer activity.

  Sun J, Mu J, Wang S, Jia C, Li D, Hua H, Cao H. Sun J, et al. J Enzyme Inhib Med Chem. 2022 Dec;37(1):431-444. doi: 10.1080/14756366.2021.2018685. J Enzyme Inhib Med Chem. 2022. PMID: 34957906 Free PMC article.
• New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies.

  Elkady H, Elwan A, El-Mahdy HA, Doghish AS, Ismail A, Taghour MS, Elkaeed EB, Eissa IH, Dahab MA, Mahdy HA, Khalifa MM. Elkady H, et al. J Enzyme Inhib Med Chem. 2022 Dec;37(1):397-410. doi: 10.1080/14756366.2021.2015343. J Enzyme Inhib Med Chem. 2022. PMID: 34961427 Free PMC article.